UNION KOREA PHARM CO.,Ltd Logo

UNION KOREA PHARM CO.,Ltd

Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.

080720 | KO

Overview

Corporate Details

ISIN(s):
KR7080720006
LEI:
Country:
South Korea
Address:
강원도 원주시 문막읍 문막공단길 246, 원주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Union Korea Pharm Co., Ltd. is a pharmaceutical company specializing in the research, development, production, and sale of prescription drugs. The company manufactures a range of specialty medicines, including antibiotics, anti-inflammatory analgesics, and skeletal muscle relaxants. Its products are available in various formulations such as solid dosage forms, liquid injections, and powder injections. Union Korea Pharm operates under strict quality control and Good Manufacturing Practice (GMP) standards. While its primary market is South Korea, the company also engages in international business, aiming to provide total healthcare solutions as a comprehensive bio-company.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Legal Proceedings Report
회생절차개시결정
Korean 8.0 KB
2025-09-16 00:00
Delisting Announcement
주권매매거래정지기간변경 (회생절차 개시결정)
Korean 5.4 KB
2025-09-15 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-09-11 00:00
Capital/Financing Update
사채원리금미지급발생
Korean 8.7 KB
2025-09-10 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(회생절차개시신청)
Korean 8.8 KB
2025-09-09 00:00
Legal Proceedings Report
주요사항보고서(회생절차개시신청)
Korean 5.5 KB
2025-09-09 00:00
Delisting Announcement
주권매매거래정지기간변경 (회생절차 개시신청)
Korean 5.4 KB
2025-09-02 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-09-01 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 7.5 KB
2025-09-01 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 7.4 KB
2025-08-29 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 7.1 KB
2025-08-29 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.9 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-08-13 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.3 KB
2025-08-11 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.7 MB

Automate Your Workflow. Get a real-time feed of all UNION KOREA PHARM CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UNION KOREA PHARM CO.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UNION KOREA PHARM CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM

Talk to a Data Expert

Have a question? We'll get back to you promptly.